概括
先进的血管接入装置 (AVAD) 对复杂的儿科尾炎有益,特别是在严重病例的年幼儿童中. 准则应该包括年龄作为在尾切除过程中使用AVAD的因素.
科学领域:
- 儿科手术 儿科手术
- 血管接入 血管接入
- 传染性疾病 传染性疾病
背景情况:
- 静脉内接入对于治疗儿童复杂尾炎至关重要.
- 先进的血管接入装置 (AVAD),包括中线,PICC和CVC,为外围管道提供了替代方案.
- 评估AVAD在儿科尾炎中的使用和结果对于优化患者护理和根据国家指南进行审计至关重要.
研究的目的:
- 评估AVAD在接受复杂尾炎手术的儿童中的利用和结果.
- 将AVAD的使用情况和并发症与已建立的国家指南进行比较.
- 在这个人群中确定与AVAD插入相关的患者和程序因素.
主要方法:
- 在英国和爱尔兰的儿科外科中心进行了一项前性的多中心观察研究.
- 在三个月内 (截至2024年1月) 从189名患有复杂尾炎的16岁以下儿童收集数据.
- 测量结果包括无计划的AVAD插入,血管接入并发症和外围管试图.
主要成果:
- AVAD插入发生在40.2%的病例中,并且与年轻的年龄,女性性别,腹内和穿孔尾炎有关.
- 非计划的AVAD插入 (6.3%) 与年轻的年龄,更高的CRP和夜间尾切除有关.
- 使用AVAD的平均时间为5天,其中12.3%的患者出现并发症.
结论:
- 对于年幼的儿童,如果发现有穿孔性尾炎,尾质量或广泛的液,应考虑在尾切除时插入AVAD.
- 该研究建议将年龄,特别是8岁的截止时间纳入现有指导方针,用于AVAD在尾炎管理中的使用.
- 这些发现支持根据患者年龄和儿科复杂尾炎的手术内发现量身定制的血管接入策略.
相关概念视频
Appendicitis-II: Diagnostic Studies and Management
146
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
146
Hemodialysis I: Introduction
310
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
310


